Cellerant Pipeline

Cellerant has two major products under development:

• CLT-008, an off-the-shelf cell-based medicine which can facilitiate engraftment in cord blood transplants (CBT) and treat neutropenia; and
  
• Antibody therapy targeting Cancer Stem Cells.